or Try an Advanced Search...

    Metabolic Disease Stocks List

    Symbol Grade Name % Change
    NAMS A NewAmsterdam Pharma Company N.V. -0.28
    RZLT B Rezolute, Inc. -5.54
    MDGL C Madrigal Pharmaceuticals, Inc. -4.66
    QURE C uniQure N.V. -8.07
    ENZ C Enzo Biochem, Inc. 0.00
    AKRO C Akero Therapeutics, Inc. -5.61
    SEPN D Septerna, Inc. 0.67
    ETNB D 89bio, Inc. -9.37
    ALRN D Aileron Therapeutics, Inc. -13.29
    HRTS D Tema Cardiovascular and Metabolic ETF -4.45
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Biopharmaceutical Medicine Disease Biotechnology Clinical Medicine Diabetes Diabetes Mellitus Dyslipidemia Lipid Lipoprotein Medication Obesity Thyroid Acute Intermittent Porphyria Adeno Associated Virus Alcohol Alipogene Tiparvovec Alzheimer’s Disease Anemia Applied Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Metabolic Disease stocks.

    Symbol Grade Name Weight
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 12.71
    HRTS D Tema Cardiovascular and Metabolic ETF 3.0
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.93
    XBI D SPDR S&P Biotech ETF 2.9
    SBIO C ALPS Medical Breakthroughs ETF 2.08
    View all Metabolic Disease ETFs...
    Compare ETFs
    Compare BBC to SBIO Compare BBC to XBI Compare SURI to SBIO

        Metabolic Disease Stocks Recent News

        Date Stock Title
        Nov 15 MDGL Madrigal Pharmaceuticals gains amid takeover speculation
        Nov 15 AKRO Akero Therapeutics to Showcase New Analyses of Phase 2b HARMONY Study in Presentations at 75th Annual AASLD The Liver Meeting® 2024
        Nov 15 ETNB 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024
        Nov 15 ALRN Aileron Therapeutics GAAP EPS of -$0.27 misses by $0.02
        Nov 15 MDGL John Paulson's Strategic Moves in Q3 2024: A Focus on Anglogold Ashanti PLC
        Nov 14 MDGL Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves
        Nov 14 ALRN Aileron Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
        Nov 13 AKRO Akero Therapeutics to Present at the Jefferies London Healthcare Conference
        Nov 13 ALRN Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis
        Nov 13 RZLT We Think Rezolute (NASDAQ:RZLT) Needs To Drive Business Growth Carefully
        Nov 13 ALRN Aileron Therapeutics Announces Positive Topline Data from Cohort 2 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
        Nov 13 ETNB 89bio drops 2%, prices $125M stock offering
        Nov 13 ETNB 89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
        Nov 13 AKRO Akero Therapeutics Advances in MASH Treatment Trials
        Nov 12 ETNB 89bio announces proposed underwritten public offering of common stock and pre-funded warrants
        Nov 12 ETNB 89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
        Nov 11 MDGL Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
        Nov 11 NAMS NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Shares Could Be 46% Below Their Intrinsic Value Estimate
        Nov 10 MDGL 1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Biopharmaceutical Biotechnology Medicine Biology Alcohol Cancer Cardiovascular Disease Diabetes Disease Hepatitis Inflammation Life Sciences Lipoprotein Molecular Biology Non Alcoholic Fatty Liver Disease Peptides Steatohepatitis Acid Acute Intermittent Porphyria Adeno Associated Virus
        Metabolic Disease

        Metabolic disease is a group of disorders that affect the body's ability to break down and use food for energy. These disorders can be caused by genetic mutations, lifestyle choices, or environmental factors. Symptoms of metabolic diseases can include fatigue, weight gain, muscle weakness, and difficulty concentrating. In some cases, metabolic diseases can lead to serious complications such as organ failure, coma, and even death.

        Browse All Tags